Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

PAVM

PAVmed (PAVM)

PAVmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PAVM
DateHeureSourceTitreSymboleSociété
24/09/202414h01PR Newswire (US)American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestNASDAQ:PAVMPAVmed Inc
16/09/202422h30PR Newswire (US)PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsNASDAQ:PAVMPAVmed Inc
10/09/202413h56PR Newswire (US)Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressNASDAQ:PAVMPAVmed Inc
03/09/202413h51PR Newswire (US)Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthNASDAQ:PAVMPAVmed Inc
20/08/202414h16PR Newswire (US)Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerNASDAQ:PAVMPAVmed Inc
13/08/202414h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAVMPAVmed Inc
13/08/202414h16PR Newswire (US)The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerNASDAQ:PAVMPAVmed Inc
13/08/202414h01PR Newswire (US)PAVmed Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
12/08/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PAVMPAVmed Inc
12/08/202414h07PR Newswire (US)Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
08/08/202414h31PR Newswire (US)Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventNASDAQ:PAVMPAVmed Inc
06/08/202414h15PR Newswire (US)Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
05/08/202414h15PR Newswire (US)Lucid Diagnostics to Participate in Upcoming Investor ConferencesNASDAQ:PAVMPAVmed Inc
30/07/202414h15PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024NASDAQ:PAVMPAVmed Inc
29/07/202414h15PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024NASDAQ:PAVMPAVmed Inc
23/07/202414h01PR Newswire (US)Lucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeNASDAQ:PAVMPAVmed Inc
11/07/202414h31PR Newswire (US)Lucid Diagnostics Launches New Corporate WebsiteNASDAQ:PAVMPAVmed Inc
02/07/202413h55PR Newswire (US)Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:PAVMPAVmed Inc
13/06/202413h58PR Newswire (US)PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteNASDAQ:PAVMPAVmed Inc
12/06/202414h05PR Newswire (US)4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
14/05/202402h43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
13/05/202414h00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
09/05/202413h49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallNASDAQ:PAVMPAVmed Inc
07/05/202413h39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsNASDAQ:PAVMPAVmed Inc
03/05/202414h35PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024NASDAQ:PAVMPAVmed Inc
02/05/202414h35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024NASDAQ:PAVMPAVmed Inc
02/05/202413h49PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
30/04/202413h35PR Newswire (US)PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteNASDAQ:PAVMPAVmed Inc
29/04/202414h47PR Newswire (US)Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthNASDAQ:PAVMPAVmed Inc
08/04/202414h30PR Newswire (US)Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PAVMPAVmed Inc
 Showing the most relevant articles for your search:NASDAQ:PAVM

Dernières Valeurs Consultées

Delayed Upgrade Clock